Organogenesis Holdings Inc. (ORGO) News

Organogenesis Holdings Inc. (ORGO): $5.46

-0.46 (-7.77%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ORGO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Filter ORGO News Items

ORGO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

ORGO News Highlights

  • ORGO's 30 day story count now stands at 6.
  • Over the past 16 days, the trend for ORGO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about ORGO are AUD, DTE and ORIC.

Latest ORGO News From Around the Web

Below are the latest news stories about Organogenesis Holdings Inc that investors may wish to consider to help them evaluate ORGO as an investment opportunity.

Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors

CANTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced the appointment of Michael J. Driscoll, Ed.D. to the Company’s Board of Directors, effective February 15, 2022. Dr. Driscoll will serve as an independent director of the Company and member of the Aud

Yahoo | February 17, 2022

Organogenesis (ORGO) Stock Jumps 7.4%: Will It Continue to Soar?

Organogenesis (ORGO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Yahoo | February 16, 2022

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February

CANTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will participate in the following upcoming investor conferences: The BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools Conference Management will partici

Yahoo | February 11, 2022

Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022

CANTON, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that fourth quarter and fiscal year 2021 financial results will be reported after the market closes on Tuesday, March 1st. Management will host a conference call at 5:00 p.m. Eastern Time on March 1s

Yahoo | February 7, 2022

Emerald Mutual Fund Advisers Trust Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA ...

Leola, PA, based Investment company Emerald Mutual Fund Advisers Trust (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, Karuna Therapeutics Inc, HireRight Holdings Corp, sells Chegg Inc, BellRing Brands Inc, Echo Global Logistics Inc, Tetra Tech Inc, ORIC Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Mutual Fund Advisers Trust.

Yahoo | February 2, 2022

Wakefield Asset Management LLLP Buys ProShares Short S&P500, Regeneron Pharmaceuticals Inc, ...

Investment company Wakefield Asset Management LLLP (Current Portfolio) buys ProShares Short S&P500, Regeneron Pharmaceuticals Inc, Goldman Sachs Group Inc, ONEOK Inc, Tapestry Inc, sells ProShares Short QQQ, DTE Energy Co, Restaurant Brands International Inc, Huntington Bancshares Inc, Activision Blizzard Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Wakefield Asset Management LLLP.

Yahoo | February 1, 2022

Here's Why Organogenesis Holdings (NASDAQ:ORGO) Can Manage Its Debt Responsibly

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Yahoo | January 24, 2022

ORGO Investors Have Opportunity to Lead Organogenesis Holdings Inc. Securities Fraud Lawsuit

Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ: ORGO).

Yahoo | January 20, 2022

Upcoming Deadline Reminder: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm

Upcoming Deadline Reminder: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the F

Yahoo | January 1, 2022

CLASS ACTION REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. (ORGO) Shareholders of Securities Fraud Class Action Lawsuit

RADNOR, PA / ACCESSWIRE / December 31, 2021 / The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Organogenesis Holdings Inc. ("Organogenesis") (NASDAQ:ORGO).

Yahoo | December 31, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.8058 seconds.